4.3 Article

Loss of lower extremity muscle strength based on diabetic polyneuropathy in older patients with type 2 diabetes: Multicenter Survey of the Isometric Lower Extremity Strength in Type 2 Diabetes: Phase 2 study

Journal

JOURNAL OF DIABETES INVESTIGATION
Volume 12, Issue 3, Pages 390-397

Publisher

WILEY
DOI: 10.1111/jdi.13354

Keywords

Diabetic neuropathy; Muscle strength; Older patients

Funding

  1. Japan Society for the Promotion of Science (JSPS) KAKENHI [15K01440, 18K10674]
  2. Grants-in-Aid for Scientific Research [18K10674, 15K01440] Funding Source: KAKEN

Ask authors/readers for more resources

The study found that DPN significantly reduced LEMS in older type 2 diabetes patients and resulted in a loss of LEMS and decrease in mobility.
Aims/Introduction Diabetic polyneuropathy (DPN) is a factor that reduces lower extremity muscle strength (LEMS) in older type 2 diabetes patients. This relationship remains unclear in longitudinal studies. Therefore, we longitudinally investigated the apparent effects of DPN on changes in LEMS. Furthermore, we cross-sectionally examined relationships among DPN, LEMS, mobility and health-related quality of life. Materials and Methods Bodyweight-normalized (relative) knee extension force (KEF) was examined in 51 DPN and 54 non-DPN patients (68.9 +/- 5.6 and 70.2 +/- 5.9 years, respectively) at baseline and follow up at 3.6 +/- 0.6 years. At follow up, mobility was measured using a 25-question geriatric locomotive function scale. Health-related quality of life was assessed using the five-dimensions of EuroQol for quality-adjusted life years calculation. Results Relative KEF in the DPN group was significantly lower at follow up (1.22 +/- 0.47 Nm/kg) than at baseline (1.31 +/- 0.47 Nm/kg;P < 0.05). DPN significantly affected changes in relative KEF. Mobility decreased by 41 and 65% in the non-DPN and DPN groups, respectively. Quality-adjusted life years were significantly lower in the DPN group (0.856 +/- 0.131) than in the non-DPN group (0.920 +/- 0.105;P < 0.01). Relative KEF was a significant independent variable that explained quality-adjusted life years. Conclusions DPN clearly reduced LEMS in older type 2 diabetes patients within 4 years. Furthermore, DPN resulted in a loss of LEMS and decrease in mobility. Therefore, DPN development should be monitored closely, with glycemic control and LEMS kept at a high level to maintain health-related quality of life in older patients with type 2 diabetes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available